RankAlpha logo
Back to Rankings

ARTL

Artelo BiosciencesF
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
View Chart
+
Peers tracked
10
U.S. public peers
Grade Position
In line
vs peer average
ARTL vs peer average
46/100
ARTL vs. peer average (F vs. F)
Grade spread
D 2 · F 7
Graded peers loaded
Coverage
10 graded
100% of tracked

Peer overview

RGNX is the first available peer comparator.

Biotech whose valuation is driven by binary clinical readouts and partnership outcomes, offering a comparably high event risk/reward profile.

✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
Top peerRGNXREGENXBIO
ARTL
Artelo Biosciences
RGNX
REGENXBIO
Grade
F
F
Momentum
1
4
Value
41
41
Sentiment
57
-
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Defensive
Defensive
Open Side-by-Side ComparisonCompare all

Grade position vs RGNX

ARTL / RGNX
Grade Position
In line
ARTL vs. peer average (F vs. F)
46/100
Momentum
1
RGNX
Value
41
ARTL
Sentiment
57
-

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs ARTL
1
RGNX
RGNX
F
20/100
Even
2
INO
INO
D
40/100
-1
3
ADIL
Adial Pharmaceuticals Inc Common
F
20/100
Even
4
INM
InMed Pharmaceuticals Inc Common
F
20/100
Even
5
RNAZ
TransCode Therapeutics Inc Common
F
20/100
Even
RGNX is the first peer returned for this comparison set.